Podcasts about Tissue engineering

February is American Heart Month, and in light of that, we're bringing back an episode about a group here at Stanford Engineering that's developing 3D printing methods for human tissues and organs, a process known as bioprinting. Motivated in part by the critical need for heart transplants, Mark Skylar-Scott and his team are specifically working to bioprint tissues of the human heart. It may sound like science fiction, but it's actually just another example of the groundbreaking research we do here. We hope you'll take another listen and be inspired by the possibilities.Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your quest. You can send questions to thefutureofeverything@stanford.edu.Episode Reference Links:Stanford Profile: Mark A. Skylar-ScottMark's Lab: The Skylar-Scott Lab | Stanford MedicineConnect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / FacebookChapters:(00:00:00) IntroductionRuss Altman introduces guest, Mark Skylar-Scott, a professor of bioengineering at Stanford University.(00:02:06) What is Bioprinting?The role of cells and biopolymers in printing functional biological structures.(00:03:31) Bioprinting a HeartThe potential of printing organs on demand, especially heart tissue.(00:04:38) Obtaining Cells for BioprintingUsing stem cells derived from the patient's own cells to create heart tissue.(00:06:29) Creating Multiple Cell Types for the HeartThe challenge of printing eleven different heart cell types with precision.(00:08:50) The Scaffold for 3D PrintingThe support material used in 3D printing and how it's later removed.(00:10:10) Cell Migration and Organ FormationHow cells organize themselves to form functional heart tissue.(00:12:08) Growing a Full-Sized HeartWhether they're printing full-sized hearts or starting with smaller organs.(00:13:34) Avoiding Overgrowth RisksThe role of bioreactors in shaping the early stages of the organ.(00:14:57) Scaling Up Cell ProductionThe need to generate massive numbers of cells for experimentation.(00:18:32) The Challenge of VascularizationCreating a blood vessel network to supply oxygen and nutrients.(00:22:35) Ethical Considerations in BioprintingConsent, stem cell sourcing, and the broader ethical landscape.(00:26:04) The Timeline for Bioprinted OrgansThe long timeline for bioprinted organs to reach clinical use.(00:27:24) The State of the Field & CollaborationThe collaborative, competitive biofabrication field and its rapid progress.(00:28:20) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook

Our latest episode features Dr. Irene de Lázaro, an Assistant Professor of Biomedical Engineering at the New York University Tandon School of Engineering. Dr. Lázaro leads the NanoBioEngineering for Tissue Reprogramming and Regeneration laboratory at NYU since 2023. Her team investigates the influence of genetic, biochemical, and mechanical signals on cell plasticity, identity, and function. Their mission is to leverage this understanding, integrating nanomedicine and bioengineering approaches, to develop therapeutic strategies that regulate cell fate—such as promoting tissue regeneration or rejuvenation—or enhance cellular function, particularly in applications like immunotherapies. Dr. Lázaro has a PharmD from the University of Alcalá in Spain and a PhD in Regenerative Medicine from the University College London, before completing her postdoctoral work at the Wyss Institute at Harvard. In this episode, we will hear about Dr. Lázaro's experiences in pursuing a research career, pursuing opportunities internationally, the obstacles facing early-career researchers, and navigating a work-life balance in the first years of her independent career.

Imagine that we could make tissues indistinguishable from those produced by humans or animals, at will, and at comparable cost to the natural products. With the rate of progress being made, it won't be imaginary much longer.If we don't need to kill animals for food, leather, or other products, then we reduce animal suffering. We increase biodiversity because we don't need to devote huge land areas to feed farm animals. And we help climate change - the meat industry is a huge contributor to greenhouse gases. This dream needs more than cultivated cells. We need to organise them into tissues, with multiple cell types in the correct places and doing the right things. Directing cells to organise into tissue structures such as leather, corneas and cultivated meat has huge implications for medicine, fashion and the food industry.Che Cannon joins me in this episode to share his work in this area. Che is the CEO of BSF Enterprise PLC, and we delve into the intersection of science and business in developing innovative technologies such as this.Che shares the complexity of tissue mechanics and the advantages of bottom-up methods over traditional top-down approaches. We also talk about the environmental benefits and ethical considerations of alternative leathers and cultivated meats. Additionally, Che explains the progress that has been made on the medical device front with corneal repair. On the business side, we also cover the unusual step by the company to raise funds by listing on the stock exchange.There are many practical applications of these technologies, and they are surely the future of sustainable materials in various industries, making these developments hugely important.“Cultivated meat has a good purpose and can lift lots of technologies.” – Che ConnonYou'll hear about:01:11 Exploring Cell and Material Interaction03:30 Tissue Engineering and Its Applications06:22 The Science Behind Lab-Grown Leather15:31 Cultivated Meat: Innovations and Challenges20:41 Macromolecular Crowding in Cell Culture25:27 The Future of Cultivated Meat28:49 Market Opportunities in Asia31:46 Corneal Repair Technology36:06 BSF Enterprise: A Unique Path to Funding40:01 Future Directions in Research and DevelopmentConnect with Che Connon:LinkedIn - https://www.linkedin.com/in/checonnon/ 3D Bio-Tissues - https://www.3dbiotissues.com/ Kerato - https://kerato.co.uk/ BSF Enterprise - https://bsfenterprise.com/ Connect with me:LinkedIn: https://www.linkedin.com/in/markdavison100/ If you need any lab equipment:Grant Instruments: https://www.grantinstruments.com/ Grant Instruments on LinkedIn: https://www.linkedin.com/company/grant-instruments-cambridge-ltd/ 

Join us for an in-depth conversation with William V. Giannobile, interviewed by Sejal Thacker, as he reflects on his key publication, Platelet-derived growth factor stimulates bone fill and rate of attachment level gain. Giannobile discusses the groundbreaking development of recombinant human platelet-derived growth factors (PDGFs) and their pivotal role in oral tissue regeneration. He traces PDGF's journey from discovery to clinical application, sharing insights into the science, trials and regulatory steps that brought this innovation to patients. From early tissue culture studies to regenerative therapies for periodontal disease, Giannobile details the research process and rigorous trials required to develop safe and effective treatments. This is a must for anyone interested in the latest developments in oral tissue regeneration!

Send us a textDiscovering new hope for hair loss! In this episode of Causes or Cures, Dr. Eeks chats with Dr. Sheila MacNeil and Dr. Muhammad Yar about their accidental discovery that a simple sugar compound may stimulate hair regrowth and help end male-pattern baldness, or androgenic alopecia—a condition affecting many people. They dive into how an unexpected finding in a study on wound healing sparked their current study on hair loss, which they break down in the episode. The researchers walk us through how the study was conducted, results, how their findings compare to current prescription treatments for hair loss, and what's next in their research.Dr. MacNeil is an Emeritus Professor of Tissue Engineering at the University of Sheffield, UK, with over 550 peer-reviewed publications in soft tissue engineering. You can learn more about Dr. MacNeil here. Dr. Yar is an Associate Professor at the Interdisciplinary Research Center for Biomedical Materials at COMSATS University in Islamabad, Pakistan. Previously, he served as an Assistant Professor at King Fahd University in Saudi Arabia. You can learn more about his work here.*New* SUBSCRIBE for Upcoming Bonus Episodes!You can contact Dr. Eeks at bloomingwellness.com.Follow Eeks on Instagram here.Or Facebook here.Or X.On Youtube.Or TikTok.SUBSCRIBE to her monthly newsletter here.Support the show

Franco Kraiselburd — Co-Founder and CEO of Asclepii — building the next generation of tissue engineering therapeutics for wound healing.I've recently heard a life's work described as a lifelong quest to build something for others that expresses who you are. It feels to me that Franco is not just building a company, but has found his life's work and is truly pursuing a grand mission.Grounded in an international childhood living across the United States, Spain, Brazil, Argentina and Chile, Franco began his scientific career at the early age of 12, and has spent the last 9 years dedicating his life to the development of accessible and impactful advanced medical devices, translating the ideas from several different labs within the Tissue Engineering field into reality and the market.After 5 years working in the University of São Paulo (Brazil), Franco moved to Cleveland, OH, to work in the Regenerative Medicine field as a Biomedical Engineering student at Case Western Reserve University with Dr. Arnold Caplan, the Father of Mesenchymal Stem Cells and the very person who's research had inspired him to set off down this path in the first place.A scientist and entrepreneur, Franco is constantly trying to bridge the worlds ideas and reality. His wound care innovations are internationally recognized, being awarded a Gold Medal at the 2019 GENIUS Olympiad, nominated for 2025 Forbes Under 30 and MIT Innovators Under 35, and a finalist in the Rising Tech Star category of Ohio's 2023 Best of Tech Awards.Accolades and recognition aside, I can just express personally having gotten to know Franco and listented to him tell his story, that his mind is a wonderful thing to behold and we're lucky to have him as an entreprenuer in Celveland-----LINKS:https://www.linkedin.com/in/francokrais/https://www.asclepii.com/home-----SPONSORS: John Carroll University Boler College of Business || Impact Architects & NinetyJohn Carroll University Boler College of Business: https://business.jcu.edu/ As we've heard time and time again from entrepreneurs on Lay of The Land — many of whom are proud alumni of John Carroll University —  success in this ever-changing world of business requires a dynamic and innovative mindset, deep understanding of emerging technology and systems, strong ethics, leadership prowess, acute business acumen… all qualities nurtured through the Boler College of Business!With 4 different MBA programs of study — spanning Professional, Online, Hybrid, and 1-Year-Flexible — The Boler College of Business provides flexible timelines and various class structures for each MBA Track — including online, in-person, hybrid and asynchronous — to offer the most effective options for you, in addition to the ability to participate in an elective International Study Tour, providing unparalleled opportunities to expand your global business knowledge by networking with local companies overseas and experiencing a new culture.The career impact of a Boler MBA is formative and will help prepare you for this future of business and get more out of your career. To learn more about John Carroll University's Boler MBA programs, please go to business.jcu.eduThe Boler College of Business is fully accredited by AACSB International, the highest accreditation a College of Business can have.Impact Architects & NinetyLay of The Land is brought to you by Ninety. As a Lay of The Land listener, you can leverage a free trial with Ninety, the platform that helps teams build great companies and the only officially licensed software for EOS® — used by over 7,000 companies and 100,000 users!This episode is brought to you by Impact Architects. As we share the stories of entrepreneurs building incredible organizations throughout NEO, Impact Architects helps those leaders — many of whom we've heard from as guests on Lay of The Land — realize their visions and build great organizations. I believe in Impact Architects and the people behind it so much, that I have actually joined them personally in their mission to help leaders gain focus, align together, and thrive by doing what they love! As a listener, you can sit down for a free consultation with Impact Architects by visiting ia.layoftheland.fm!-----Stay up to date by signing up for Lay of The Land's weekly newsletter — sign up here.Past guests include Justin Bibb (Mayor of Cleveland), Pat Conway (Great Lakes Brewing), Steve Potash (OverDrive), Umberto P. Fedeli (The Fedeli Group), Lila Mills (Signal Cleveland), Stewart Kohl (The Riverside Company), Mitch Kroll (Findaway — Acquired by Spotify), and many more.Connect with Jeffrey Stern on LinkedIn — https://www.linkedin.com/in/jeffreypstern/Follow Jeffrey Stern on X @sternJefe — https://twitter.com/sternjefeFollow Lay of The Land on X @podlayofthelandhttps://www.jeffreys.page/

What happens to the human body in deep space? Neil deGrasse Tyson, Chuck Nice and Gary O'Reilly explore tissue engineering, Wolverine & Deadpool's healing style, and the science to help humans adapt to long-term space travel with biomedical engineer Ronke Olabisi.NOTE: StarTalk+ Patrons can listen to this entire episode commercial-free here: https://startalkmedia.com/show/engineering-humans-for-deep-space-with-ronke-olabisi/Thanks to our Patrons Micheal Morey, Kristoff Vidalis, Adir Buskila, Yanir Stein, Randombot38, James Komiensky, Richard Clark, Daniel Helwig, Kayleigh Sell, and KENNY SMART for supporting us this week.

Send us a Text Message.Prof. Dr. Alan Widgerow, MBBCh, FCS, MMed, FACS, is Division Chief, Research, Center for Tissue Engineering ( https://sites.uci.edu/ctelab/team/ ) and Adjunct Professor Plastic Surgery, Dept of Plastic Surgery, University of California, Irvine ( https://faculty.uci.edu/profile/?facultyId=6048 ) and Chief Scientific Officer and Head of Skin Science Center of Innovation at Galderma ( https://www.galderma.com/ ).Prof. Widgerow is a plastic surgeon who ran a solo private practice in South Africa for over 20 years. Prof. Widgerow completed his undergraduate and post-graduate studies at the University of the Witwatersrand, South Africa. He has held various positions in numerous academic and professional associations including that of President of the Association of Plastic and Reconstructive surgery of Southern Africa (APRSSA). He is author of over 190 plastic surgical related publications and 2 books. He was also the founder and medical director of 13 wound clinics in South Africa. Prof. Widgerow relocated to Irvine California in Dec 2009 to pursue his interests in medical device innovations, cosmeceuticals and wound care, but he still plays an active role in academic medicine world-wide. In 2012 he was appointed to the Faculty of the University of California Irvine Plastic Surgery Dept as Full Adjunct Professor and Director of the Center for Tissue Engineering and in 2021 was appointed as its Division Chief of Research. He is involved in multiple projects related to adipose derived stem cell and adipose decellularized matrix, wound healing and transplantation. In 2018 he was awarded the Distinguished Faculty Mentor of the year Award by the Institute for Clinical and Translational Science, UCI. Prof. Widgerow has developed and licensed multiple products in the US and South African markets. In 2015 he joined ALASTIN Skincare, Inc. an early start up professional skin care company as their Chief Medical Officer. Over the past 6 years he has spearheaded the scientific innovations team introducing multiple new products based on novel wound healing pathways. The resulting products have been validated with gene expression, in vitro and ex-vivo testing, biopsies, and multiple clinical trials resulting in a range of products that have surpassed previous scientific validations in this space. He continues to pursue patented novel concepts, peptide technologies and vigorous testing thus contributing to Alastin Skincare's position as the fastest growing professional skin care company in the US for the past 4 years. In 2021, Alastin Skincare was acquired by Galderma, the largest privately owned dermatology company in the world, and in June 2022, Prof. Widgerow was appointed Chief Scientific Officer of Galderma, Head of the Skin Science Center for Innovation and Head of Alastin innovations. He is involved in aesthetic, prescription and consumer product science research and development.#AlanWidgerow #CenterForTissueEngineering #PlasticSurgery #UniversityOfCalifornia #Irvine #ChiefScientificOfficer #SkinScience #Galderma #Dermatology #ExtracellularMatrix #StemCells #Exosomes #ECM #Aging #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast  #STEM #Innovation #Technology #Science #ResearchSupport the Show.

In our latest episode, we feature Dr. Brooke Coley, a bioengineer and social justice scholar. Currently, she is an Assistant Professor at the Polytechnic School of the Ira A. Fulton School of Engineering at Arizona State University (ASU). She is the founding Executive Director of the Center for Research Advancing Racial Equity, Justice, and Sociotechnical Innovation Centered in Engineering (RARE JUSTICE). Dr. Coley earned her Ph.D. in Bioengineering with a concentration in Biomechanics from the University of Pittsburgh. She also completed her Bachelor of Science in Chemical Engineering at the University of Maryland Baltimore County as a Meyerhoff Scholar. Prior to joining the Polytechnic School, she completed her postdoctoral training at ASU in engineering education. Dr. Coley's research lies at the intersection of racial equity, mental health and qualitative research methods encompassing critical theory, participation action research, and arts-based research methods. In this episode, we gain insight into Dr. Coley's career trajectory and how she has dealt with adversity and used her experiences to become an agent of change and advocate for inclusion in all levels of her work. Join us as we learn more about Dr. Coley's unique academic journey and how she hopes to push the bounds of traditionally heteronormative engineering environments through transdisciplinary approaches. 

A best of episode where Russ interviews one of his bioengineering colleagues,  Fan Yang, about some of the fascinating work she's doing in the realm of tissue engineering. Hear more about the ways her lab is modeling human tissue to help develop a better understanding of how we might effectively replace damaged tissues and alleviate a number of health concerns.Episode Reference Links:Fan Yang's Stanford Profile: WebsiteFan Yang's Stanford Lab: WebsiteEp.174 Regenerating and Rejuvenating Human Tissues: Website / YouTube (original episode) Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads or Twitter/XConnect with School of Engineering >>> Twitter/XChapters:(00:00:00) IntroductionHost Russ Altman introduces guest Fan Yang, a bioengineer at Stanford.(00:03:15) The Basics of Tissue EngineeringThe purpose and significance of tissue engineering, emphasizing its role in addressing critical medical needs like late-stage arthritis.(00:04:23) Challenges in Tissue EngineeringTechnical hurdles in creating viable tissues for clinical use, such as integrating these tissues into the human body.(00:07:00) 3D Printing and In Situ PolymerizationTechnological advances in shaping tissues using 3D printing and the benefits of in situ polymerization to adapt to complex tissue shapes.(00:09:15) Specific Challenges with CartilageThe challenges specific to cartilage regeneration, explaining why it has been a difficult tissue to replicate and heal.(00:13:56) Micro Ribbon Based HydrogelsExplanation of micro ribbon based hydrogels, a new development aimed at improving tissue regeneration.(00:19:16) Cancer Research and Tissue EngineeringHow tissue engineering technologies are not only pivotal for therapeutic uses but also crucial for understanding diseases and aiding drug discovery.(00:24:38) Regulatory Challenges and CommercializationThe regulatory and commercialization challenges facing new medical technologies, including the need for industry partnerships and the role of the FDA(00:26:20) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads or Twitter/XConnect with School of Engineering >>> Twitter/X

Today's guest is Christine Schmidt who is a University of Florida faculty member and former department share who works in regenerative neural tissue engineering. Top 3 Takeaways: "We're trying to create scaffolds that can be templates for the body to repair itself, to grow around, and ultimately become natural tissue, seamlessly integrating with the body's own." "Other faculty were discouraging. This is because academia tends to prioritize scholarly pursuits such as papers and grants, often undervaluing applied work and its real-world applications."  "Our clinical collaborator actively participated in the lab alongside Sarah. Together, they would work on batches, with Sarah creating formulations and providing immediate feedback based on the tactile experience. The collaborator would discern whether a material was suitable for surgical use, offering invaluable insights into the practicalities surgeons face." 0:45 Can you introduce yourself better than I just did? 1:15 What is tissue engineering? 5:00 How did you get into this? 8:30 By focusing on entrepreneurial endeavors you were at risk of not getting tenure, how did you still get it? 14:15 Which was more useful for your career, entrepreneurial or academic? 16:45 How was your technology licensed?  22:15 Do you want to talk about your other startup, Alafare? 32:30 You then moved to Florida and then eventually became department chair, why did you do that? 36:45 How did you do the department chair and research at the same time? 37:45 Is there anything else that we didn't talk about that you wanted to mention?

Ben Greenfield Fitness Key Takeaways The future is now with stem cell treatments for longevity – stem cell treatments can be targeted, dosed, and have predictable outcomes like pharmaceuticals In early trials, stem cells transplanted into the brain created new dopamine neurons and put Parkinson's disease into remissionTo tackle longevity, we need to go back to first-order principles of wellness: muscle, inflammation, oxidative stressTip: have an accountability system, whether it's a health coach or buddy who will hold you to it  Medicine 4.0 is on the horizon, allowing people greater access to gene therapy treatments to help people increase their healthspan Look out for klotho, NK cell treatments, placental implants, and Vagus nerve blocks to become common practiceRead the full notes @ podcastnotes.orgAre you tired of feeling the effects of aging, like sluggish muscles, persistent inflammation, and a general slowdown? Imagine receiving a treatment that not only decelerates these processes but also enhances muscle growth and restores your energy at the cellular level. In this episode, Dr. Adeel Khan, a repeat guest, unveils the revolutionary treatments offered at his clinic, Eterna Health, such as follistatin gene therapy and Klotho injections. These cutting-edge treatments combat the aging process, helping you feel youthful and vibrant — stay tuned to hear about my personal experience during my visit to his Cabo location. As the CEO and founder of Eterna Health, a revolutionary concept in specialized healthcare, Dr. Khan's allure extends beyond borders. Patients from across the globe seek out his unwavering dedication to understanding cellular physiology and the art of cellular repair, leading to collaborations with scientists in Canada, the USA, Mexico, Dubai, Italy, and Japan. Dr. Khan's grand vision reaches beyond personal success. His ultimate aspiration is to democratize regenerative medicine, making it affordable and accessible to people from all walks of life. Join Dr. Khan and me as we explore the benefits of cutting-edge treatments for slowing down the aging process, enhancing muscle growth, improving overall health, and innovative approaches to regenerative medicine, shedding light on the future of anti-aging therapies. Oh, and if you didn't catch our first interview together, I highly recommend checking that out here: “The Difference Between Getting Stem Cells Internationally Vs. The USA, Peptides, Testosterone & Hormones, Tissue Engineering, DNA Editing, Truths & Myths Of Regenerative Medicine & More.” For the full show notes, visit: https://bengreenfieldlife.com/eternapodcast Episode sponsors: Jigsaw Health: Visit JigsawAC.com and use “Greenfield10” to get 10% off on your order.  Mary Ruth's Organics: Use code MROBENG20 for 20% off (valid on both maryruthorganics.com and Amazon). Limitless Life Nootropics: Visit limitlesslifenootropics.com/bengpeptides and use code BEN  for an exclusive discount. Ipothecary: Go to ipothecarystore.com/ben and using code BEN20 for 20% off. Wild Health: Get 20% off with code BEN at wildhealth.com/benSee omnystudio.com/listener for privacy information.

Are you tired of feeling the effects of aging, like sluggish muscles, persistent inflammation, and a general slowdown? Imagine receiving a treatment that not only decelerates these processes but also enhances muscle growth and restores your energy at the cellular level. In this episode, Dr. Adeel Khan, a repeat guest, unveils the revolutionary treatments offered at his clinic, Eterna Health, such as follistatin gene therapy and Klotho injections. These cutting-edge treatments combat the aging process, helping you feel youthful and vibrant — stay tuned to hear about my personal experience during my visit to his Cabo location. As the CEO and founder of Eterna Health, a revolutionary concept in specialized healthcare, Dr. Khan's allure extends beyond borders. Patients from across the globe seek out his unwavering dedication to understanding cellular physiology and the art of cellular repair, leading to collaborations with scientists in Canada, the USA, Mexico, Dubai, Italy, and Japan. Dr. Khan's grand vision reaches beyond personal success. His ultimate aspiration is to democratize regenerative medicine, making it affordable and accessible to people from all walks of life. Join Dr. Khan and me as we explore the benefits of cutting-edge treatments for slowing down the aging process, enhancing muscle growth, improving overall health, and innovative approaches to regenerative medicine, shedding light on the future of anti-aging therapies. Oh, and if you didn't catch our first interview together, I highly recommend checking that out here: “The Difference Between Getting Stem Cells Internationally Vs. The USA, Peptides, Testosterone & Hormones, Tissue Engineering, DNA Editing, Truths & Myths Of Regenerative Medicine & More.” For the full show notes, visit: https://bengreenfieldlife.com/eternapodcast Episode sponsors: Jigsaw Health: Visit JigsawAC.com and use “Greenfield10” to get 10% off on your order.  Mary Ruth's Organics: Use code MROBENG20 for 20% off (valid on both maryruthorganics.com and Amazon). Limitless Life Nootropics: Visit limitlesslifenootropics.com/bengpeptides and use code BEN  for an exclusive discount. Ipothecary: Go to ipothecarystore.com/ben and using code BEN20 for 20% off. Wild Health: Get 20% off with code BEN at wildhealth.com/benSee omnystudio.com/listener for privacy information.

Entdecken Sie mit uns die Geheimnisse eines stabilen Kniegelenks und der Bedeutung des Knorpels für die optimale Gelenkfunktion. Dr. Wolfgang Zinser, ein Pionier im Bereich Gelenkerhalt, teilt seine unersetzlichen Erfahrungen und erklärt, warum nicht jeder Knorpelschaden direkt zum Gelenkersatz durch eine Prothese führen muss. Lassen Sie sich von seinen Erkenntnissen über die ersten Anzeichen und Symptome von Knorpelschäden und Arthrose fesseln und verstehen Sie, warum ein frühes Eingreifen die Schlüsselrolle spielt, um die Notwendigkeit eines Gelenkersatzes zu umgehen. Wir garantieren Ihnen, dass Sie nach diesem Gespräch einen neuen Blick auf die Gesundheit Ihrer Knie erhalten werden und vorbereitet sind, Warnsignale für eine Arthrose richtig zu deuten.In diesem Podcast berichten wir über die neuesten Durchbrüche in der Knorpelregenerations-Technik, vergleichen bahnbrechende Methoden der Zellanzüchtung und beleuchten, wie die Zusammenarbeit unterschiedlicher medizinischer Disziplinen zu hoffnungsvollen Therapieansätzen führt. Dr. Zinser bietet einen tiefen Einblick in die Welt der Knorpelregeneration, von Minced Cartilage bis hin zu Zelltransplantationen, und teilt mit uns, warum kontinuierliche Weiterbildung und Forschung das Rückgrat eines jeden medizinischen Fortschritts sind. Tauchen Sie mit uns ein in eine Episode, die vollgepackt ist mit Fachwissen und lebensverändernden Ratschlägen für jeden, der die Gesundheit seiner Gelenke ernst nimmt.Music under CC License: Artist: Jahzzar, Track: Blueprint (License: CC BY-SA 4.0 DEED)Artist: Breuss Arrizabalaga Quintet, Track: Mount Fuji (License: CC PD)

In our latest episode, we feature Dr. Elisa Cimetta, an Associate Professor in the Department of Industrial Engineering at the University of Padua and Principal Investigator of the BIAMET laboratory (Biomedical Applications of Multiscale Engineering Technologies). Dr. Cimetta obtained her Ph.D. from the University of Padua and conducted postdoctoral research at Columbia University, where she co-founded EpiBone, a Columbia University spinoff devoted to producing engineered bone and osteochondral patient-specific tissues. Her journey to academia was marked by innovative research and collaborations, leading her to her current position as a Visiting Research Scientist at Prof. Vunjak-Novakovic's laboratory. In this episode, we explore Dr. Cimetta's trajectory, exploring her pivotal moments, research interests, and the challenges and rewards of launching a new research group. Join us as we uncover Dr. Cimetta's insights on navigating academia and forging a successful career path in engineering and biomedical research. 

Fan Yang, PhD is an Associate Professor at Stanford University with joint appointments in the Departments of Orthopaedic Surgery and Bioengineering joins OsteoBites to discuss her work on tissue engineering strategies for elucidating OS biology and drug discovery.Fan Yang, PhD is the founder and Director of Stanford Stem Cells and Biomaterials Engineering Laboratory, and also Co-director of Stanford NIH Biotechnology Training Program. Her research seeks to develop hydrogels with unique micro- and nano- scale properties to promote stem cell differentiation, tissue regeneration and immunomodulation, with a focus on musculoskeletal diseases. Her lab also harnesses biomaterials to create 3D cancer models with in vivo-mimicking phenotype and drug responses. Such 3D models could enable discovering novel druggable targets that would otherwise be missed using conventional 2D culture, and enable high-throughput drug screening with reduced cost and time than animal models. Prior to joining Stanford, Dr. Yang received her Ph.D. in Biomedical Engineering from Johns Hopkins University, and then completed a postdoctoral fellowship at MIT under Prof. Robert Langer. In recognition of her innovation, she has been recognized by numerous awards including Fellow of American Institute for Medical and Biological Engineering, MIT TR35 Global list honoree, National Science Foundation CAREER award, Young Investigator Award from Society for Biomaterials, Biomaterials Science Lectureship Award, Young Investigator award from Alliance for Cancer and Gene Therapy, Ellen Weaver Award by the Association for Women in Science, Baxter Faculty Scholar Award, the McCormick Faculty Award, Stanford Asian American Faculty Award, and the Basil O'Connor Starter Scholar Research Award, etc.

Mark Skylar-Scott is one of the world's foremost experts on the 3D printing of human tissue, cell by cell. It's a field better known as bioprinting. But Skylar-Scott hopes to take things to a level most never imagined. He and his collaborators are working to bioprint an entire living, working human heart. We're printing biology, Skylar-Scott tells host Russ Altman on this episode of Stanford Engineering's The Future of Everything podcast.Episode Reference Links:Skylar-Scott LabConnect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads or Twitter/XConnect with School of Engineering >>> Twitter/XChapters:(00:00:00) IntroductionHost Russ Altman introduces the episode, guest Mark Skylar-Scott and his work bioprinting the heart.(00:02:15) What is Bioprinting & Tissue Engineering?Explanation of bioprinting and its distinction from traditional 3D printing. Overview of the technology and its applications in tissue engineering and how to get the cells for this purpose.(00:06:37) Engineering the Cells of the HeartThe 11 different cell types of the heart that are being created, and the steps involved in printing them, scaffolding them, and how they form tissue.(00:12:23) Building Hearts: Size and Growth ConsiderationsThe scale of bio-printed hearts, potential strategies for growth and integration, & technical challenges in controlling cell growth and development. (00:15:05) Scaling Up Cell ProductionThe importance of scaling up cell production for efficient experimentation. Exploration of the transition from laboratory research to clinical implementation. (00:18:40) Vascularization: The Key to Functional Bioprinted OrgansCritical importance of creating a comprehensive vascular network & the challenges of integrating capillaries and ensuring nutrient delivery to all cells. (00:23:00) Ethical Considerations in BioprintingExamination of the ethical issues surrounding the use of human cells in bioprinting, focusing on consent and the potential for inequality in access due to cost.(00:26:12) The Future of Bioprinting: Timeline and Field DynamicsProjections about the timeline for the clinical application of bio-printed organs and the state of collaborative competition within the fabrication field. (00:28:28) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads or Twitter/XConnect with School of Engineering >>> Twitter/X

In this podcast episode, MRS Bulletin's Laura Leay interviews Hamideh Khanbareh and Vlad Jarkov of the University of Bath in the UK about an application they introduced for using piezoelectric materials in tissue engineering. The researchers fabricated a composite by combining polydimethylsiloxane with a piezoelectric material of potassium-sodium-niobate that is compatible with cell lines similar to neurons. They then studied how the composite material would interact with neural stem cells. They found that the piezolectrically activated composites allowed the cells to spread across the surface of the material and saw an increase in the amount of neurons. Usually the use of piezoelectric materials in tissue engineering requires mechanical stimulation from either movement of the body or the application of ultrasound. In this research, no additional mechanical stimulation was required. This work was published in a recent issue of Advanced Engineering Materials. 

(1:00) - Scientists 3D-print hair follicles in lab-grown skin

Dr. Pankaj Karande is an Associate Professor in Chemical and Biological Engineering at Rensselaer Polytechnic Institute. Pankaj was trained as a chemical engineer, and his research aims to apply engineering approaches and technology to solve problems in biology and healthcare to improve the quality and quantity of human life. Projects in his lab span areas such as drug discovery, drug delivery, biomaterials, diagnostics, and more. When he's not working, Pankaj loves to cook, and experimenting with different recipes has been a great way to relieve stress. He was awarded his B.S. in Chemical Engineering from Mumbai University Institute of Chemical Technology and his Ph.D. in Chemical Engineering from the University of California, Santa Barbara. Pankaj was awarded an Anna Fuller Postdoctoral Fellowship in Molecular Oncology, and he conducted postdoctoral research in the Center for Cancer Research at Massachusetts Institute of Technology before joining the faculty at Rensselaer. Pankaj has received a variety of awards and honors in his career, including the Excellence in Classroom Instruction Award and the Outstanding Teaching Award from Rensselaer Polytechnic Institute. He also received the Alzheimer's Association New Investigator Research Award, the Goldhirsh Brain Tumor Research Award, and a Bronze Edison Award in the Best New Product in Science and Medical Category. In addition, he has been issued multiple patents in the areas of Transdermal Formulation Discovery and Novel High Throughput Screening Platforms. In our interview, Pankaj shares more about his life and science.

Our new episode features Dr. Hunter Rogers, Investment Research Analyst at a globally and nationally ranked academic medical center. Prior to this role, Dr. Rogers was an Equity Research Associate with a focus on biotech investment opportunities at William Blair. Previously, Dr. Rogers also served as a Postdoctoral Research Assistant at Northwestern University. Dr. Rogers has a Bachelor of Engineering and a Master of Science in Chemical Engineering from Auburn University, and a PhD in Life Sciences from Northwestern University. In this episode we discuss with Dr. Rogers his career journey, highlighting the influence of his entrepreneurial experience during his PhD and postdoctoral training in his transition to a career in biotech investment. We talked about the several skills Dr. Rogers sharpened along the way as he also provides us with an insightful glimpse into the world of equity research and biotech investment.

Dr. Claire Higgins is a Reader (faculty) in Tissue Engineering and Regenerative Medicine in the Department of Bioengineering at Imperial College London. She is also President of the European Hair Research Society and Vice President of the Institute of Trichologists, a professional association for researchers who study the hair and scalp. Claire teaches and conducts research in the areas of tissue engineering and regenerative medicine. She uses skin and hair follicles as models to better understand how tissues respond to injury, heal wounds, and repair after disease. Outside of science, making pottery has been one of Claire's favorite pastimes since she took her first classes as a postdoc. She enjoys making items like bowls, vases, and lamp bases on her pottery wheel in her studio during her free time. Claire received her B.Sc. in natural sciences and her PhD in skin developmental biology from Durham University in England. Afterwards, she conducted postdoctoral research at Columbia University. She worked as an Associate Research Scientist at Columbia University before joining the faculty and starting her laboratory at Imperial College London in 2014. In our interview, she shares more about her life and science.

In this episode we chat with Dr. Aaron Dingle, a visionary in the field of tissue engineering and limb transplantation. From the University of Wisconsin, Aaron unravels the complexities of developing artificial limbs and neuroprosthetics, sharing how advancements in this area can drastically improve the lives of those with lost limbs. Fueled by impactful personal experiences and a fascination with science fiction, Dr. Dingle provides insights into the symbiotic relationship between science fiction fantasies and real-world technological innovations, reflecting on the influence of films like Star Wars on his career trajectory.Get guest updates and submit your listener questions via Instagram: https://instagram.com/travellingscience/Aaron opens up about his daily grind and long-term goals, highlighting the challenges of translating laboratory successes into clinically viable solutions. The episode is not just about science; it's about persistence, creativity, and the constant quest for knowledge. Peppered with humor and grounded in reality, our discussion offers an inside look at the tireless efforts to mend the human body through the extraordinary potential of regenerative medicine.Dr. Aaron Dingle has a Ph.D in vascular tissue engineering from the University of Melbourne's O'Brien Institute of Microsurgery in Melbourne Australia. He is currently a Senior Scientist and Co-Director of the Microsurgery and Regenerative Medicine Lab at the University of Wisconsin in Madison, USA.Donations:During this episode, a donation was made to Surf Life Saving Australia.https://slsfoundation.com.au/Travelling Science is currently my passion project. If you enjoy the podcast and would like to support it in some way, you can make a contribution here: https://www.patreon.com/thetravellingscientistLinks:Dr. Aaron Dingle's Laboratory Websitehttps://www.surgery.wisc.edu/research/researchers-labs/microsurgery-and-regenerative-medicine-lab/Microsurgery Websitehttps://microsurgeryeducation.org/Prosthetic Hand Historyhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128433/

This week comedian Nabil Abdulrashid tells us how laughter and comedy reduced the levels of violence in prison, heart surgeon Professor Massimo Caputo describes how he used tissue engineering in a world-first life-saving heart operation, neuroscientist Dr Adam Kampff brings us an incredible insight into the human brain by taking us from rats that play video games to the birth of language and human civilisation, and historian Phillipa Vincent-Connolly transports us back to Henry VIII's court to explore the lives of disabled courtiers. Best Medicine is your weekly dose of laughter, hope and incredible medicine. Award-winning comedian Kiri Pritchard-McLean is joined by funny and fascinating comedians, doctors, scientists and historians to celebrate medicine's inspiring past, present and future.Each week, Kiri challenges her guests to make a case for what they think is 'the best medicine', and each of them champions anything from world-changing science to an obscure invention, an every-day treatment, an uplifting worldview, an unsung hero or a futuristic cure.Whether it's micro-robotic surgery, virtual reality syringes, Victorian clockwork surgical saws, more than a few ingenious cures for cancer, world-first lifesaving heart operations, epidurals, therapy, dancing, faith or laughter - it's always something worth celebrating.Hosted by Kiri Pritchard-McLeanFeaturing: Nabil Abdulrashid, Professor Massimo Caputo, Dr Adam Kampff and Phillipa Vincent-ConnollyWritten by Laura Claxton, Charlie George, Rajiv Karia, Pravanya Pillay, Kiri Pritchard-McLean and Ben RowseProducer: Ben WorsfieldAssistant Producer: Tashi RadhaExecutive Producer: Simon NichollsTheme tune composed by Andrew JonesA Large Time production for BBC Radio 4

#621: Today, we're sitting down with Carolina Reis Oliveira, co-founder of OneSkin. Carolina holds her Ph.D. in Stem Cell Biology and Tissue Engineering & in 2016, Carolina relocated to Silicon Valley from Latin America to co-found OneSkin and lead the development of the company's disruptive skin age reversal technologies. Today, Carolina joins us to discuss skincare from a scientific perspective. We dive into all things aging and anti-aging, identify which "hot" products can actually damage your skin in the long run, and she reveals the top 5 free things you can do for your skin in terms of anti-aging. We also explore which products are best for achieving better skin, why the skin around your eyes ages differently than the rest of your body, and why the health of your skin serves as a direct indicator of your overall health.   To connect with OneSkin click HERE To connect with Lauryn Evarts Bosstick click HERE To connect with Michael Bosstick click HERE Read More on The Skinny Confidential HERE To subscribe to our YouTube Page click HERE For Detailed Show Notes visit TSCPODCAST.COM To Call the Him & Her Hotline call: 1-833-SKINNYS (754-6697) This episode is brought to you by The Skinny Confidential & OneSkin Visit www.oneskin.co and use code SKINNY15 for 15% off your first purchase. This episode is brought to you by Fable Pets Fable Pets designs gear that solves problems for you and your pet, so the two of you can enjoy exploring the world together. Go to fablepets.com/skinny for 20% off sitewide and up to 35% off sets. This episode is brought to you by JSHealth JSHealth Vitamins is a science-focused vitamin and wellness brand that provides targeted formulas to help you meet your personal health goals, created using the highest quality ingredients backed by research. Go to jshealthvitamins.com/skinny and use code SKINNY for 20% your order or first subscription. This episode is brought to you by Hiya Health Hiya Health fills in the most common gaps in modern children's diet to provide full-body nourishment our kids need with a yummy taste they love. Go to hiyahealth.com/skinny to receive 50% off your first order. This episode is brought to you by AG1 If you want to take ownership of your health, it starts with AG1. Go to drinkAG1.com/SKINNY to get a free 1-year supply of Vitamin D3K2 AND 5 free AG1 Travel Packs with your first purchase. This episode is brought to you by MOON MOON Oral Beauty is reimagining oral care by elevating the everyday oral care routine into an oral care beauty experience. Get 20% off your first device purchase by using code SKINNY at moonoralbeauty.com . This episode is brought to you by Momentous Visit livemomentous.com/skinny and use code SKINNY at checkout for 15% off your first purchase. Produced by Dear Media  

This podcast is a commentary and does not contain any copyrighted material of the reference source. We strongly recommend accessing/buying the reference source at the same time. ■Reference Source https://www.ted.com/talks/nina_tandon_could_tissue_engineering_mean_personalized_medicine ■Post on this topic (You can get FREE learning materials!) https://englist.me/90-academic-words-reference-from-nina-tandon-could-tissue-engineering-mean-personalized-medicine-ted-talk/ ■Youtube Video https://youtu.be/-jE2Y_6k9SU (All Words) https://youtu.be/z9czQfSGD80 (Advanced Words) https://youtu.be/F_d5puNbnR4 (Quick Look) ■Top Page for Further Materials https://englist.me/ ■SNS (Please follow!)

Dr. Nathaniel Huebsch is an Assistant Professor of Biomedical Engineering at Washington University in St. Louis. His lab focuses on understanding how mechanical cues originating at cell-cell and cell-extracellular matrix contacts influence signaling and fate. They are especially interested in how those cues affect heart development and disease. He talks about cardiac models and cardiomyocyte maturity.

Are you intrigued by the power of stem cells and regenerative medicine but left with questions every time you try to learn more? Questions like:  What's better: your own stem cells or a different source? Is it true stem cells "don't work" without some kind of scaffolding to "grow on"? Do you need to combine stem cells with exosomes? Are tissue engineering and gene editing as dangerous as they sound? Can stem cells be combined with peptides and hormones, and if so, how? In this enlightening conversation with Dr. Adeel Khan, you'll have the opportunity to hear the answers to all those questions and many more (that you may not even know you had!). Dr. Adeel Khan is an internationally recognized expert in regenerative medicine, having treated numerous high-profile celebrities and athletes. After earning his MD from the University of Ottawa in Canada, he specialized in sports medicine and led one of the first Health Canada-approved clinical trials with mesenchymal stromal cells. Adeel is now the Chief Scientific Officer of Science & Humans and the co-founder of xALT. In the discussion with Adeel, you'll discover the science of enhancing stem cell function, the difference between stem cells and progenitor cells, the future of gene editing and its interaction with cell therapy and tissue engineering, and even get a sneak peek into Dr. Khan's unique daily routine for optimal health. Full Show Notes: https://bengreenfieldlife.com/drkhan Episode Sponsors: Big Bold Health: Right now, Big Bold Health is offering listeners of this podcast 10% off your order. You can use this for Microbiome Rejuvenate, Himalayan Tartary Buckwheat Flour or any other single product. Visit  BigBoldHealth.com use code BEN10 for 10% off. HVMN: Visit  hvmn.me/BenG and use code BENG20 for 20% off any purchase of Ketone-IQ️. This is an exclusive offer for podcast listeners. Hiya: Get your kids the full-body nourishment they need to grow into healthy adults. We've worked out a special deal with Hiya for their best-selling children's vitamin. Receive 50% off your first order at hiyahealth.com/BEN. (not available on their regular website)  Cured Nutrition: Experience enhanced sleep and wake refreshed with CURED's sleep-enhancing formulas. Visit www.curednutrition.com/ben, use coupon code BEN at checkout to save 20% on any transformative blends. Organifi Sunrise: Organifi's Sunrise Kit includes their signature Green, Red, and Gold Juice blends. Get free shipping and 20% off your order of the Sunrise to Sunset Kit by going to organifi.com/ben. Fart of War: The Fart of War is a hilarious, slightly odorous card game designed by my sons and me as part of our first-ever father-son gaming company, Fried Pickles Games. fartofwar.com.See omnystudio.com/listener for privacy information.

Timestamps: 03:22 - Swiss women in STEM 08:10 - The high demand for incontinence testing 10:07 - Positive feedback from trials 15:29 - The challenges when conducting trials 20:17 - Funding difficulties About Deana Mohr-Haralampieva:  Deana Mohr-Haralampieva is the CEO & co-founder at MUVON Therapeutics, a groundbreaking startup developing a therapeutic platform for the regeneration of skeletal muscle tissue. With a background in radiopharmaceutical sciences, tissue engineering, and STEM cell therapies, Deana has extensive research experience, including a Master of Science in Cellular and Molecular Biology from the University of Konstanz, and she continued to focus on tissue repair therapy with a Ph.D. from ETH. She boldly transitioned into the startup world, driven by her passion for bringing innovative solutions to life. MUVON Therapeutics was originally  a life science spin-off  from the University of Zurich developing a therapeutic platform for regenerating skeletal muscle tissue based on autologous cells, repairing damaged tissue, and increasing the regenerative potential of weakened muscles. Their initial area of focus  was the treatment of stress urinary incontinence in women, supporting them respectfully throughout their journey to a healthier and better quality of life.  The societal challenges surrounding women in STEM fields are a constant obstacle for female founders in these fields. The need for increased female representation and dispelling stereotypes is as relevant as ever, as Deana herself has encountered misconceptions about her work, but she has also experienced firsthand the progress made in this regard, witnessing a positive shift in the number of women joining STEM courses. The goal for MUVON Therapeutics is to continue making strides in regenerative medicine and open up trials for more varied groups of women to have access to this therapy, and to also make it accessible for men. The long-term goal would be international reach by expanding to the US and the rest of Europe. Memorable quotes: "Pharma can be a scarier world than the startup world, but our project was already on the go, so we decided to stay onboard and see it through: and here we are!" "Seeing the muscle fibers twitching in the lab, I knew this would work, and we decided to make it happen." Don't forget to give us a follow on our Twitter, Instagram, Facebook and Linkedin accounts, so you can always stay up to date with our latest initiatives. That way, there's no excuse for missing out on live shows, weekly give-aways or founders dinners!

June 21, 2023: Nina Tandon, CEO and Co-Founder at EpiBone joins Bill for the news. What is the background story of EpiBone and its technology? How do stem cells play a role in EpiBone's approach to tissue engineering? Is there a risk of rejection when using a patient's own stem cells for tissue regeneration? What are some applications of EpiBone's technology in clinical trials? How do healthcare entrepreneurs and consumer companies contribute to the development of personalized medicine?Key Points:EpiBone's technologyStem cells and tissue engineeringApplications in bone and cartilage regenerationAvailability and distribution of the technologySocietal impact and ethicsPersonalized medicineConsumer-driven healthcare innovationTED Talks:Could tissue engineering mean personalized medicine?Caring for engineered tissue"The Patient Experience - A Technology Perspective" is a live webinar that explores the intersection of healthcare and technology, focusing on enhancing the patient experience. As healthcare systems prioritize patient-centered care, leveraging technology becomes crucial. Join us on July 6th, 1:00 PM ET and join the discussion! Register Here.

Jodbhir (Jod) Mehta, PhD, is the Head of the Tissue Engineering and Stem Cell Group at the Singapore Eye Research Institute and Head of the Corneal Service and Senior Consultant in the Refractive Service of the Singapore National Eye Center (SNEC).Dr. Mehta, a corneal and refractive surgery expert, has spent most of his career in Singapore, a small, thriving nation with one of the most successful healthcare systems in the world. But he trained in London and Birmingham, England.Dr. Mehta could have stayed in England and done quite well. Instead, he chose to continue his career in Singapore, a country where he could make an even deeper impact.He arrived, to a new country and a new culture, with $500, knowing no one. That was over 15 years ago.With podcast host Sophia Pathai, MD, PhD, Dr. Mehta shares why his unconventional path—to pursue a fellowship on a small island thousands of miles away—made all the difference.He also discusses his research into corneal transplantation, his early adoption of femtosecond lasers, and how his research has informed his clinical practice.Finally, he gives a glimpse into Singapore's biotech industry, which he compares to Israel for its strong ecosystem of investors and innovators. It's driven, he says, by a population with an inherent can-do attitude and a high bar for success.Listen to the podcast today to discover:Dr. Mehta's background, from neurosurgery in London to ophthalmology in Singapore.The personal and professional challenges he faced upon relocating from London to Southeast Asia.His thoughts on the Singapore economy and biotech industry.His research in corneal disease, including clinical trials related to corneal disease treatments and publications related to corneal disease and refractive surgery.How Dr. Mehta passes on his techniques to the physicians of the future.His thoughts on the potential of the metaverse for training and teaching, as well as generative AI as a tool for both patients and physicians.Advice for physician trainees interested in a career in ophthalmology, and why it's “the most exciting field, hands-down.”[Press Play]

Cristina Canal Barnils (Barcelona 1977) is Associate professor at the Department of Materials Science and Engineering, at the Technical University of Catalonia (UPC), head of the PlasmaMedLab: Plasmas for BioMedical Applications Laboratory and of the Medical Technologies: Biomaterials & Tissue Engineering research group at the IRSJD. Before joining UPC, she did different research stages at pre and postdoctoral level in different national and international research centres. She has participated and lead a number of research projects, as well as technology transfer projects in the areas of Textile materials, Biomaterials and Cold Plasmas. Her research has led to above 60 publications, and several invited conferences. Her research has been recognized with different awards, including the L'Oreal-Unesco fellowship “For Young Women in Science” (2012), the “2018 Early Career Award in Plasma Medicine“ and the  ICREA Acadèmia 2020. Her interests are focused in cold plasmas for biomedical applications, particularly: i. Surface modification of biomaterials to control parameters such as adhesion or biological behaviour; ii. Control of drug release from biomaterials; and iii. Therapeutical appications of cold plasmas, for instance, in bone cancers. She is currently ERC APACHE project Starting Grant leader in a project in the field of atmospheric pressure plasma therapy, her main axis of research being currently focused in the atmospheric pressure plasma therapy of bone cancer treatment in combination with biomaterials. --- What We Do at MIB Agents: PROGRAMS: ✨ End-of-Life MISSIONS ✨ Gamer Agents ✨ Agent Writers ✨ Prayer Agents ✨ Healing Hearts - Bereaved Parent Support ✨ Ambassador Agents - Peer Support ✨ Warrior Mail ✨ Young Adult Survivorship Support Group ✨  EDUCATION for physicians, researchers and families: ✨ OsteoBites, weekly webinar & podcast with thought leaders and innovators in Osteosarcoma ✨ MIB Book: Osteosarcoma: From our Families to Yours ✨ RESEARCH: Annual MIB FACTOR Research Conference ✨ Funding $100,000 annually for OS research ✨ MIB Testing & Research Directory ✨ The Osteosarcoma Project partner with Broad Institute of MIT and Harvard ... Kids are still dying with 40+ year old treatments. Help us MakeItBetter. 

(3:00) - 3D printing with bacteria-loaded ink produces bone-like compositesThis episode was brought to you by Mouser, our favorite place to get electronics parts for any project, whether it be a hobby at home or a prototype for work. Click HERE to learn about how additive manufacturing is being leveraged in the medical industry from bone replacement to dental guides!

We are honored to have Dr. Jennifer Morgan joining us for today's episode! Dr. Morgan is a Senior Scientist and Director of the Eugene Bell Center for Regenerative Biology and Tissue Engineering at the Marine Biological Laboratory (MBL) in Woods Hole, MA.She received her Ph.D. in Neurobiology from Duke University, where she worked on mechanisms of neurotransmission. She then carried out her postdoctoral studies on membrane trafficking in the Cell Biology Department at Yale University. In 2007, Morgan joined the Section of Molecular Cell and Developmental Biology at The University of Texas at Austin as an Assistant Professor where she expanded her research program to include spinal cord injury and regeneration mechanisms. Dr. Morgan received her first research grant from the Morton Cure Paralysis Fund, which eventually led to a Research Project Grant (R01) from the National Institutes of Health that is now in its 11th year of funding. While at UT-Austin, Dr. Morgan received several prestigious awards, including a University of Texas Regents' Outstanding Teaching Award (2011) and the Janett Trubatch Career Development Award from the Society for Neuroscience (2011). In 2012, Dr. Morgan was recruited to the MBL's Bell Center to expand her research program in regenerative biology. She continues to study the mechanisms of neurotransmission under both normal conditions, as well as with spinal injury and neurodegenerative disorders such as Parkinson's disease. Dr. Morgan is currently one of the co-directors of the NIH-funded courses at the MBL called “Frontiers in Stem Cells and Regeneration”, and she is a standing member on the NIH Neuronal Communications Study Section. Throughout her career, Dr. Morgan has dedicated her efforts to mentoring students and postdocs and advancing diversity and inclusion in the STEM sciences, and she is actively involved in the MBL Diversity and Inclusion Advisory Committee, which she chaired for the last 3 years.Marine Biological Laboratory: https://www.mbl.edu/ Many thanks to Dr. Morgan for her work and for being our guest on today's episode! This production is a collaborative effort of volunteers working to create a quality audio and visual experience around the subject of spinal cord injury. A special shout out of appreciation to Clientek for providing studio space and top-notch recording equipment. Most importantly, thank YOU for being part of the Spinal Cast audience!Interested in watching these episodes?! Check out our YouTube playlist! https://youtube.com/playlist?list=PL40rLlxGS4VzgAjW8P6Pz1mVWiN0Jou3v If you'd like to learn more about the MCPF you can visit our website - https://mcpf.org/ Donations are always welcomed - https://mcpf.org/you-can-help/

Regenerative Medicine Today welcomes Ms. Julia Hart.  Ms. Hart is the supervisor of the Histology Core Laboratory for the McGowan Institute for Regenerative Medicine. Ms. Hart discusses her work in processing, embedding, cutting, and staining of histology samples for laboratories across the University of Pittsburgh. To access the photos referenced in the podcast, [...]

Dr. Madeleine Oudin - Cancer and epilepsy researcher Dr. Madeleine Oudin, a biomedical engineering assistant professor, focuses her research on how cancer spreads throughout the body. She's also an epilepsy researcher. She organizes scientific meetings, too. In fact, she's doing one for the Tissue Engineering and Regenerative Medicine International Society (TERMIS). We chatted about her decision to become an academic, her choice of research interests, and what it takes to organize a conference. Hopefully she's well aware that a good conference must have snacks, and they must be plentiful. To learn more about Dr. Oudin, visit http://www.madeleineoudinlab.com/. __ TEACH THE GEEK teachthegeek.com/tips for public speaking tips Prefer audio? Go to podcast.teachthegeek.com @teachthegeek (FB, Twitter) @_teachthegeek_ (IG, Tik Tok)

This week on the Life Science Success Podcast my guest is Jitendra Pant.  He is an experienced Researcher with 13+ years of expertise in Clinical and Translational Research, Biocompatible Invasive Biomedical Devices, In vitro Biology, FDA approved Immunotherapeutic (Cancer and Autoimmune disorders), Bioprocess Development, Antibacterial, and Antithrombotic Biomaterials, Tissue Engineering applications, Macro and Microencapsulation technology for making artificial pancreas for Type 1 Diabetes (T1D) treatment.  He is also an entrepreneur and 2x TEDx Speaker.

Andrew Ridley, Ph.D., joins Hannah to discuss Cellink's achievement in winning the New Product Award at SLAS Europe 2022. Ridley explains what 3D bioprinting is and how BIO CELLX, the innovative biodispenser from Cellink, is shaping the future of drug discovery and tissue engineering. Also, Ridley shares a glimpse into what Cellink has in store for future products and how Cellink can provide to anyone wanting to use their technology without any tissue engineering experience.  To learn more about Cellink, visit: https://www.cellink.com/About Andrew Ridley, Ph.D.:Ridley is an experienced Product Manager/Sales Director with a Ph.D. focused in Molecular and Cellular Biology and has a history of working in the biotechnology industry. Skilled in molecular/cell biology with a focus on cutting-edge technologies including microfluidics and 3D bioprinting.Stay connected with SLAS:Online at www.slas.orgFacebookTwitter @SLAS_OrgLinkedInInstagram @slas_orgYouTubeAbout SLAS:SLAS (Society for Laboratory Automation and Screening) is an international professional society of academic, industry and government life sciences researchers and the developers and providers of laboratory automation technology. The SLAS mission is to bring together researchers in academia, industry and government to advance life sciences discovery and technology via education, knowledge exchange and global community building.  For more information about SLAS, visit www.slas.org.SLAS publishes two peer-reviewed and MEDLINE-indexed scientific journals, SLAS Discovery and SLAS Technology. For more information about SLAS and its journals, visit www.slas.org/publications.Upcoming SLAS Events:SLAS 2022 Americas Sample Management SymposiumSeptember 15-16, 2022La Jolla, CA, USARegistration is now open for the 2022 AI Data Pipelines for Life Sciences Symposium in Seattle, WA, September 26-27.This two-day symposium will allow participants to explore how AI data pipelines are integrated into the life sciences. Attendees will learn about MLOPS, applications, techniques, and architectures of data and their uses in the life sciences. The SLAS 2022 Bio Entrepreneurship Symposium will allow emerging bio entrepreneurs, start-up companies, academics and those considering bio-entrepreneurship to explore the start-up ecosystem. Register by visiting: https://www.slas.org/events-calendar/slas-2022-bio-entrepreneurship-symposium/attend/register/

(1:05) - Machine Learning Understands the Human Gut(15:43) - A  Major Step Forward in Organ Biofabrication--As always, you can find these and other interesting & impactful engineering articles on Wevolver.com.To learn more about this show, please visit our shows page. By following the page, you will get automatic updates by email when a new show is published. Be sure to give us a follow and review on Apple podcasts, Spotify, and most of your favorite podcast platforms!

Regenerative Medicine Today welcomes Dr. Antonio D'Amore.  Dr. D'Amore is a Research Assistant Professor in the Departments of Surgery and Bioengineering at the University of Pittsburgh and a group leader and head of the cardiac tissue engineering program at Fondazione RiMED. He discusses his research in cardiac tissue engineering as well as his [...]

Crowned as the Arab Top Innovator in 2020, Lebanese biotech entrepreneur Waddah Malaeb participated in Stars of Science, a top-notch Qatari innovation competition and docu-reality TV show, winning the program's 12thseason with the highest number of public and jury votes. Waddah joins our host Lynn on this episode of the Beirut Buzz podcast to tell you all about his winning product: a cost-effective biochip that replicates the human body tissues, providing an atmosphere for safe and practical drug testing. How was Waddah introduced to the world of biomedical engineering? What was the biggest challenge he faced during the creation process? And what advice would he give to aspiring entrepreneurs living in Lebanon? Hit the play button and get an answer to all these questions! You can watch season 12 of Stars of Science on the show's Youtube channel, and follow Waddah's journey on Instagram @Waddah Malaeb. Also be sure to follow us for more interesting content, @beirutcityguide on Instagram, Twitter, and Facebook, and Beirut Videos on YouTube. The Beirut Buzz is available on Anchor, Apple Podcast, and Spotify.

Explore medicine of the future with two Pediatric Cardiothoracic Surgeons and pioneer researchers. Drs. Sunjay Kaushal (Lurie Children's Hospital of Chicago) and Jolanda Kluin (Academic Medical Center; Amsterdam, Netherlands) discuss stem cell therapies for single ventricle patients, tissue engineering for heart values and a soft robotic heart. Co-Hosts: Deanna Tzanetos, MD (Norton Children's Hospital) and Saidie Rodriguez, MD (Children's Hospital of Atlanta). Editor and Producer: Saidie Rodriguez. Sponsored by Lurie Children's Hospital of Chicago.

About Suman Das and DDM Systems: Founder of DDM Systems, a Silicon Valley venture backed digital manufacturing company. Entrepreneur in the commercialization of disruptive technologies for additive manufacturing. Chair Professor of Advanced Manufacturing Systems at Georgia Tech with broad expertise in advanced and additive manufacturing techniques. Thirty years of experience in research, design, development, and optimization of additive manufacturing techniques for polymers, high temperature metals, ceramics, and composites with applications in aerospace turbine engines, resorbable implants for tissue regeneration, precision investment casting ceramic molds, polymer nanocomposites, and solid oxide fuel cells. Expert in equipment and process design, and process control for additive manufacturing. Materials processing expertise involving various lasers and length scales as well as large-area laser microfabrication and nanofabrication, maskless photopolymerization, and maskless lithography. Specialties: Direct Digital Manufacturing, Additive Manufacturing, 3-D Printing, Direct Part Manufacturing, Nanoscience and Nanotechnology, Laser Microfabrication and Nanofabrication, Photopolymerization, Maskless Lithography, Rapid Prototyping, Design and Manufacturing, Lasers, Laser Materials Processing, Biomaterials, Biomedical Implants, Tissue Engineering, Aerospace materials and structures, Superalloys, Fuel Cells. Additive Manufacturing of Ceramics, Nickel-base Superalloys, Polymers and Polymer Nanocomposites. DDM Systems is an Atlanta-based additive manufacturing and 3D printing startup. The company was founded in 2012 by Suman Das and John Halloran to rapidly commercialize LAMP™and SLE™, two disruptive manufacturing technologies with immediate applications in the aerospace and industrial gas turbines sectors. Large Area Maskless Photopolymerization (LAMP™) is a breakthrough additive technology for the tool-less, on-demand and affordable direct digital manufacturing (DDM) of ceramic cores and integral-cored shell molds for investment casting of high-precision, high-performance turbine engine hot-section components such as airfoils. LAMP produced ceramic cores are fully compatible with current investment casting foundry practices. Scanning Laser Epitaxy (SLE™) builds upon over two decades of metal powder bed-based laser additive manufacturing experience and achieves a breakthrough in manufacture and repair of high-value turbine engine hot-section components made of non-weldable superalloys. SLE achieves controlled epitaxial deposition of equiaxed (EQ), directionally-solidified (DS) and single-crystal (SX) materials to produce fully dense, crack-free structures. This capability surpasses existing metal additive techniques. In response to the rapidly growing demand for both technologies, DDM Systems will deliver commercial systems in 2015.

Dr. David Hay is the Chair of Tissue Engineering at the University of Edinburgh, where his group is defining novel ways to produce liver tissue from PSCs. They use in vitro derived tissue to better model human liver physiology and to develop supportive cell based therapies for disease. Dr. Hay also founded Stimuliver, a company that is developing a disruptive liver implant to treat critically failing liver function in humans. He talks about hepatocyte differentiation, liver disease modeling, and automating the production of cell therapies.

Meet Nina Tandon, Ph.D.:Nina Tandon, Ph.D. is the CEO and co-founder of EpiBone. She is a TED Senior Fellow, Adjunct Professor of Electrical Engineering at the Cooper Union, and a former Staff Associate Postdoctoral Researcher in the Laboratory for Stem Cells and Tissue Engineering at Columbia University. Dr. Tandon is also the co-author of “Super Cells: Building with Biology.” She received a Master's in Electrical Engineering from MIT, and a Ph.D. in Biomedical Engineering and an MBA from Columbia University.Key Insights:Nina Tandon, Ph.D. realized that the technologies running our bodies are a lot like the wires and hard drives that we build with our hands. Nina works in the technology between cells and circuits.Alternative Funding. EpiBone was incubated in Academia. Initial funding for research came from a translation grant. Grants are a good option for academic entrepreneurs like Dr. Tandon, because writing grant proposals is familiar, the rigorous peer review serves as due diligence, and the grant funding de-risks the investment. (8:03)EpiBone Explained. EpiBone technology utilizes a patient's own stem cells to grow bone or cartilage into the shape and structure that patient needs. EpiBone has started with facial bones, but sees a future with orthopedic applications. (11:52)Entrepreneurship is like the Olympics. All Olympians should have coaches, and CEOs are no different. What is demanded of Dr. Tandon is constantly changing. Coaching helps her understand her weaknesses, manage stress, and realize problems before they magnify. (23:47)This episode is hosted by Aaron Martin. He is a member of the Advisory Council for Day Zero and is Executive Vice President and Chief Digital Officer at Providence, and Managing General Partner of Providence Ventures. Relevant Links:Learn more about EpiBoneRead “Why Every Life Science CEO Needs a Leadership Coach” by Nina TandonWatch “Personalized Surgery: Growing Your Own Bone” by Slice of MIT

I sat down with Professor of Cellular and Biomolecular Engineering at the University of Texas at Austin, Elizabeth Cosgriff-Hernandez. Dr. Cosgriff-Hernandez and I discussed her laboratories investigations in the fields of tissue and polymer engineering, the importance of diversity in the scientific workforce, and her path to scientific success.     SHOW LESS    

If we can build living tissue whose form is patterned off natural organs, will it have the same function? Jordan Miller, PhD discusses the design space of engineered living tissues and the challenges presented. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37581]

If we can build living tissue whose form is patterned off natural organs, will it have the same function? Jordan Miller, PhD discusses the design space of engineered living tissues and the challenges presented. Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 37581]

(1:01) - Team Builds First Living Robots - That Can Reproduce(11:30) - Tissue Engineering Using Mechanobiology And Micromanipulation

This week on the CWC podcast I sit down with Dr. Kevin Brenner, a board certified plastic and reconstructive surgeon with over 15 years experience in private practice in Beverly Hills, California. A native of Los Angeles, Dr Brenner obtained his Board certification in General Surgery, completed a fellowship in Tissue Engineering, and was Board certification in Plastic Surgery following his second residency in Plastic Surgery at UC Irvine. He has been in private practice and on staff at Cedars Sinai Medical Center since 2006. Together, we discuss breast implant illness, his experiences with patients who have explanted, how BII and explanting are beginning to be discussed at medical seminars, and "The Brenner Breast Team," where he has combined his post surgery services with holistic wellness as well. You'll love hearing Dr. Brenner's openness to understanding more about BII, and his decision to begin collecting data with his patients to better understand the illness.Caroline's Linktree: https://linktr.ee/carolinecmathiasDr. Brenner's website: https://www.kevinbrennermd.comContact Dr. Brenner's office: 310.777.5400